Request Pricing
Book a Demo
Request Pricing
Book a Demo
Menu
Angebot anfordern
Bewertung ausführen

Newsroom / COVID-19 tests

The latest product releases, company news and microsampling industry updates from neoteryx.

COVID-19 Tests? Consider a Finger-Prick Instead of a Regular Blood Draw

by Neoteryx, on April 29,2020

COVID-19 Tests? Consider a Finger-Prick Instead of a Regular Blood Draw

“COVID-19 testing is top-of-mind for every researcher around the world at present, and effective testing is an important part of every coronavirus pandemic safety plan. Testing can potentially be done …

Read Story
Topics:remote blood samplingCOVID-19 tests
Prev All Posts Next

search our newsroom

news reporter resources:

If you don’t find the information & assets you need via the buttons below, please contact us here: press@neoteryx.com

Fact Sheet & FAQs

Neoteryx Experts

Media Contacts

Media Assets

Scientific Research Publications

social media

subscribe to news

Drop us a line

Neoteryx, LLC

421 Amapola Ave
Torrance, CA 90501
Call us: 1 (310) 787-8747
info@neoteryx.com
The Mitra Microsampler class I medical device is for direct specimen collection and transportation of blood and other biological fluids. It is not specific to any clinical test, and is not for use in diagnostic procedures. Use of the Mitra Microsampler in Laboratory Developed Tests (LDTs) requires further processing including the establishment of performance characteristics and successful validation by the laboratory in a manner consistent with CLIA requirements. The Mitra Microsampling Device is a FDA listed Class 1 exempt device. Neoteryx operates a Quality Management System (QMS) that is based on FDA good manufacturing practices, 21 CFR 820 regulations, and ISO-13485. 
Copyright © 2019 Neoteryx, LLC. All rights reserved.